jain.com
The Analysis · Companies · People · Methodology

Equity Rights Offering deadline extended

Company: Core Scientific

This claim was marked delayed on October 10, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
financing
Statement date
2023-12-20
Promised by
2023-12-28
Current status
delayed

What the later record shows

The date slipped · new target January 5, 2024

The ERO participation deadline did not end on December 28, 2023. A later filing says the subscription period expired on January 5, 2024.

“The subscription period for the ERO expired on January 5, 2024.”
2024-11-05 · Core Scientific 10-Q filed 2024-11-06 View cached copy (2026-08-31)Live source ↗

Checked October 10, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.

The claim, verbatim

The deadline for participating in the Company's Equity Rights Offering has been extended to Thursday, December 28, 2023

Source (primary)

Core Scientific 8-K filed 2023-12-21 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗

Quote: “the deadline for participating in the Company's previously announced Equity Rights Offering has been extended to Thursday, December 28, 2023”

How we checked this

Checked on October 11, 2026. The cited source supports every part of this claim.

The 8-K states that, as a result of the Global Plan Settlement, the deadline for participating in the Company's previously announced Equity Rights Offering was extended to Thursday, December 28, 2023 (subject to further extension).

Confirmed in the source:

What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312523300548/d416493d8k.htm) in full (9,888 characters, retrieved August 31, 2026) and checked each assertion in the claim against it.

Additional evidence

confirms Core Scientific 8-K filed 2023-12-21

Quote: “the deadline for participating in the Company's previously announced Equity Rights Offering has been extended to Thursday, December 28, 2023”

View cached copy (2026-08-31)Live source ↗

delays Core Scientific 10-Q filed 2024-11-06

Quote: “The subscription period for the ERO expired on January 5, 2024.”

View cached copy (2026-08-31)Live source ↗

Record of changes

September 3, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 4, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 9, 2026 — outcome unconfirmed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
October 10, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.